Saguindang, Blezcy .
HRN: 03-09-38 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2025
CEFUROXIME 500MG (TAB)
10/12/2025
10/19/2025
PO
500
Bid
Thickly Msaf
Checking Final Appropriateness
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes